JP2019200084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019200084A5 JP2019200084A5 JP2018093813A JP2018093813A JP2019200084A5 JP 2019200084 A5 JP2019200084 A5 JP 2019200084A5 JP 2018093813 A JP2018093813 A JP 2018093813A JP 2018093813 A JP2018093813 A JP 2018093813A JP 2019200084 A5 JP2019200084 A5 JP 2019200084A5
- Authority
- JP
- Japan
- Prior art keywords
- blood
- fiber
- pka
- tubular body
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 239000000306 component Substances 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 6
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000007992 BES buffer Substances 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- 239000007994 TES buffer Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HYSZWUPCSXTPSX-UHFFFAOYSA-N 2-(4-ethylpiperazin-1-yl)ethanol Chemical compound CCN1CCN(CCO)CC1 HYSZWUPCSXTPSX-UHFFFAOYSA-N 0.000 description 1
- MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 1
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018093813A JP6954865B2 (ja) | 2018-05-15 | 2018-05-15 | ファイバーロッド、血液採取器具、及び血液検査キット |
| US16/391,336 US11241690B2 (en) | 2018-05-15 | 2019-04-23 | Fiber rod, blood collection instrument, and blood test kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018093813A JP6954865B2 (ja) | 2018-05-15 | 2018-05-15 | ファイバーロッド、血液採取器具、及び血液検査キット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019200084A JP2019200084A (ja) | 2019-11-21 |
| JP2019200084A5 true JP2019200084A5 (enExample) | 2020-10-01 |
| JP6954865B2 JP6954865B2 (ja) | 2021-10-27 |
Family
ID=68534033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018093813A Active JP6954865B2 (ja) | 2018-05-15 | 2018-05-15 | ファイバーロッド、血液採取器具、及び血液検査キット |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US11241690B2 (enExample) |
| JP (1) | JP6954865B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013202778A1 (en) * | 2013-03-14 | 2014-10-02 | Gen-Probe Incorporated | Systems, methods, and apparatuses for performing automated reagent-based assays |
| USD983407S1 (en) * | 2020-10-20 | 2023-04-11 | Verrica Pharmaceuticals Inc. | Ampule crush tool |
| CN114414306B (zh) * | 2022-01-13 | 2025-01-10 | 杭州安旭生物科技股份有限公司 | 一种样本采集装置及样本采集方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6138608A (ja) * | 1984-07-31 | 1986-02-24 | Fuji Photo Film Co Ltd | 全血からの血漿の分離器具および分離方法 |
| US7323144B2 (en) | 2002-03-18 | 2008-01-29 | Leisure, Inc. | Apparatus for separating biological sample and separating method of the same |
| KR101761426B1 (ko) | 2009-04-28 | 2017-07-25 | 덴카 세이켄 가부시키가이샤 | 간이 멤브레인 어세이 장치 |
| WO2012145379A1 (en) | 2011-04-19 | 2012-10-26 | Porex Corporation | Liquid sampling, storage, transfer and delivery device |
| JP6518630B2 (ja) * | 2015-07-06 | 2019-05-22 | 富士フイルム株式会社 | 血液検査キット及び血液分析方法 |
-
2018
- 2018-05-15 JP JP2018093813A patent/JP6954865B2/ja active Active
-
2019
- 2019-04-23 US US16/391,336 patent/US11241690B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019200084A5 (enExample) | ||
| JP2017015712A5 (enExample) | ||
| JP2018185335A (ja) | 尿検査装置および定量的尿検査用乾燥試薬 | |
| Self | Direct analysis in real time-mass spectrometry (DART-MS) for rapid qualitative screening of toxic glycols in glycerin-containing products | |
| Shukla et al. | Conformal solutions: which model for which application? | |
| CN103499654B (zh) | 工作场所空气中碱金属及其化合物的采集方法及测定方法 | |
| Kouri et al. | ISLH recommended reference procedure for the enumeration of particles in urine | |
| JP2017015711A5 (enExample) | ||
| JP6954865B2 (ja) | ファイバーロッド、血液採取器具、及び血液検査キット | |
| JP2017012129A5 (enExample) | ||
| Fransson et al. | Laboratory evaluation of a new evidential breath-alcohol analyser designed for mobile testing–the Evidenzer | |
| CN106950303A (zh) | 生物样本血液中苯系物的测定方法 | |
| Petrov et al. | Investigation on sources of contamination, for an accurate analytical blank estimation, during measurements of the Fe content in seawater by isotope dilution inductively coupled plasma mass spectrometry | |
| Cappon et al. | A simple and rapid procedure for the gas-chromatographic determination of methylmercury in biological samples | |
| WO2015129869A1 (ja) | 尿試料分析方法、尿試料分析用試薬及び尿試料分析用試薬キット | |
| TW201009337A (en) | Analytical method to monitor vaccine potency and stability | |
| Stanley | Proteins of normal and pathological human thyroid tissue | |
| Oleinikova et al. | Liquid–liquid coexistence curves of re-entrant phase transitions beyond the asymptotic range: tetrahydrofuran+ water and tetrahydrofuran+ heavy water | |
| Rajadhyaksha et al. | Development of LC-MS/MS method for quantification of Lurasidone using volumetric absorptive microsampling (VAMS); a comparative study between dried blood and plasma samples | |
| JPH073423B2 (ja) | 沈澱試薬及びそれを使用する螢光偏光イムノアツセイ | |
| JP6461005B2 (ja) | 血清又は血漿中の低密度リポ蛋白の凍結乾燥による変性抑制剤及び変性抑制方法 | |
| Johnson et al. | Determination of aluminum in biological fluids by furnace atomic absorption spectrophotometry | |
| WO2012090909A1 (ja) | 脂溶性の測定方法 | |
| Wieling et al. | Selection of robust combinations of extraction liquid composition and internal standard: Monte Carlo simulation of improvement of assay methods with liquid—liquid extraction prior to high-performance liquid chromatography | |
| Hain et al. | EPA 533 and 537.1 with the Novel LCMS-8050RX: Demonstration of Instrument and Method Performance to meet PFAS regulatory levels |